Unfounded claims about SARS-CoV-2’s origin continue to circulate, further complicating efforts to maintain a constructive, evidence-based public discourse.

The vast majority of people in a study with long COVID had experienced multiple SARS-CoV-2 infections over the course of a 4-year period, researchers reported.

US FDA approves Novavax's Nuvaxovid 2025-2026 Formula Covid-19 vaccine: Gaithersburg, Maryland Friday, August 29, 2025, 11:00 Hrs [IST] Novavax, Inc. announced that the US Food an ...

"With today's approval, we will work with our partner Sanofi to provide access to a protein-based, non-mRNA COVID-19 vaccine for eligible individuals this fall," said John C. Jacobs, President and ...